Exact Mass: 306.1135
Exact Mass Matches: 306.1135
Found 288 metabolites which its exact mass value is equals to given mass value 306.1135,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cimitin
Cimifugin is an oxacycle and an organic heterotricyclic compound. Cimifugin is a natural product found in Eranthis cilicica, Ostericum grosseserratum, and other organisms with data available. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
Fluconazole
Fluconazole is only found in individuals that have used or taken this drug. It is a triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS. [PubChem]Fluconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Fluconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis. J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Z-Gly-Pro
KEIO_ID Z003; [MS3] KO009084 KEIO_ID Z003; [MS2] KO009083 KEIO_ID Z003
trans-O-Methylgrandmarin
trans-O-Methylgrandmarin is found in citrus. trans-O-Methylgrandmarin is a constituent of satsuma mandarins (Citrus unshiu). Constituent of satsuma mandarins (Citrus unshiu). trans-O-Methylgrandmarin is found in citrus.
6-O-Desmethyl-mycophenolic acid
6-O-Desmethyl-mycophenolic acid is a metabolite of mycophenolic acid. Mycophenolic acid or mycophenolate is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. It was initially marketed as the prodrug mycophenolate mofetil (MMF) to improve oral bioavailability. More recently, the salt mycophenolate sodium has also been introduced. Mycophenolic acid is commonly marketed under the trade names CellCept and Myfortic. (Wikipedia)
Propylenediamine tetra-acetic acid
Metioprim
C254 - Anti-Infective Agent > C258 - Antibiotic
5-(Hydroxymethyl)-6-(3,5-dimethoxy-4-hydroxyphenyl)-8-oxabicyclo[3.2.1]octa-3-ene-2-one
1-(4-methoxyphenyl)-3-(thiomorpholin-4-yl)pyrrolidine-2,5-dione
8alpha-acetoxy-3alpha,4alpha-epoxy-1alpha-hydroxyguai-9,11(13)-dien-6alpha,12-olide
1,7,8,9-Tetrahydro-1,9-dihydroxy-4-methoxy-5-methyl-8-(1-methylethenyl)-3H-furo[3,4-f][1]benzopyran-3-one
(2S)-5-hydroxy-2-(1-hydroxy-4-oxocyclohexyl)-7-methoxychroman-4-one|(2S)-ongokein-4-one
(2E,6E)-8-(2,4,5-trihydroxyphenyl)-2,6-dimethyl-8-oxo-2,6-dienoic acid|orirubenone B
Methyl 5-acetoxymethanol-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate|methyl 5-acetoxymethyl-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate
1,4,6-trihydroxy-2-methoxy-7-methyl-5,6,8,8a,9,10a-hexahydro-7,9-epoxyanthracen-10-one|fusaquinon A
(-)-erythro-6-(1,2-dihydroxy-3-methylbut-3-enyl)-7,8-dimethoxy-[2H]-chromen-2-one|(-)-fatouain A
(+)-fatouain E|(+)-threo-8-hydroxy-6-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxy-[2H]-chromen-2-one
6-(2,3-Dihydroxy-3-methylbutyl)-7-acetoxy-2H-1-benzopyran-2-one
(S)-2,5,7-trihydroxy-3-(5-hydroxyhexyl)-1,4-naphthoquinone
(Z)-6-benzylidene-3-hydroxymethyl-1,4-dimethyl-3-methylsulfanylpiperazine-2,5-dione
2-(2-Hydroxypentyl)-4-oxo-7-methoxy-4H-1-benzopyran-5-carboxylic acid
(+/-)-6-(1-ethoxyethyl)-5-hydroxy-2,7-dimethoxynaphthoquinone|6-(1-Ethoxyethyl)-5-hydroxy-2,7-dimethoxy-1,4-naphthoquinone
2-(hydroxymethyl)-6-naphthalen-2-yloxyoxane-3,4,5-triol
fluconazole
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3238; ORIGINAL_PRECURSOR_SCAN_NO 3236 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3247; ORIGINAL_PRECURSOR_SCAN_NO 3245 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3228; ORIGINAL_PRECURSOR_SCAN_NO 3225 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3241; ORIGINAL_PRECURSOR_SCAN_NO 3237 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3236; ORIGINAL_PRECURSOR_SCAN_NO 3231 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3230; ORIGINAL_PRECURSOR_SCAN_NO 3229 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6761; ORIGINAL_PRECURSOR_SCAN_NO 6759 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6801; ORIGINAL_PRECURSOR_SCAN_NO 6798 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6803; ORIGINAL_PRECURSOR_SCAN_NO 6800 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6824; ORIGINAL_PRECURSOR_SCAN_NO 6823 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6831; ORIGINAL_PRECURSOR_SCAN_NO 6829 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6836; ORIGINAL_PRECURSOR_SCAN_NO 6832 CONFIDENCE standard compound; INTERNAL_ID 2352 CONFIDENCE Parent Substance (Level 1); INTERNAL_ID 2300 CONFIDENCE standard compound; INTERNAL_ID 8598 INTERNAL_ID 8598; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 328 EAWAG_UCHEM_ID 328; CONFIDENCE standard compound
5-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
Cimifugin
Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
C16H18O6_3H-Oxireno[h][3]benzoxacyclododecin-7,13(2H,8H)-dione, 1a,4,5,13a-tetrahydro-10,12-dihydroxy-5-methyl
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione_major
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,?]heptadeca-1(17),13,15-triene-2,11-dione
Gly Gly Ser Ser
Gly Ser Gly Ser
Gly Ser Ser Gly
Ser Gly Gly Ser
Ser Gly Ser Gly
Ser Ser Gly Gly
trans-O-Methylgrandmarin
N-(4-amino-2-methoxy-5-methylphenyl)-4-methylbenzenesulfonamide
ethyl 4-hydroxy-5,6,8-trimethoxynaphthalene-2-carboxylate
Potassium (4-tert-butoxycarbonylpiperazin-1-yl)methyltrifluoroborate
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
4-((4-Methylpiperazin-1-yl)Methyl)phenylboronic acid
3-methoxy-6-methyl-1-(3,4,5-trimethoxyphenyl)pyridazin-4-one
Ethyl 4-hydroxy-1-(2-methoxyethyl)-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
N-(3-PHENYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-2(3H)-YLIDENE)ANILINE
5-(N-TERT-BUTOXYCARBONYLAMINOMETHYL)-4-PHENYL-1,2,4-TRIAZOLE-3-THIOL
[5,5-Biisobenzofuran]-1,1,3,3-tetrone, dodecahydro-
(2R,5S)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one Hydrochloride
(3-((TERT-BUTYLDIMETHYLSILYL)OXY)-2,4,6-TRIFLUOROPHENYL)BORONIC ACID
4H-1,4-BENZODIAZEPINE-4,8-DICARBOXYLIC ACID-1,2,3,5-TETRAHYDRO-2-OXO-4-(1,1-DIMETHYLETHYL) ESTER
N-cyano-N-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester
15,17-Dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.03,5]heptadeca-1(13),14,16-triene-2,11-dione
(2S)-2-[2-[[(4R)-4-amino-4-carboxybutyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid
2-[2-[3-[Acetyl(hydroxy)amino]propylamino]-2-oxoethyl]-2-hydroxybutanedioic acid
4-(4-nitrophenyl)-N-prop-2-enyl-1-piperazinecarbothioamide
Ethyl 4-(3-methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide
N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide
4-[(3-Cyano-4,6-dimethyl-2-pyridinyl)thio]-3-oxobutanoic acid propan-2-yl ester
1-(2,3-Dihydroindol-1-yl)-2-(5-pyridin-4-yl-2-tetrazolyl)ethanone
2-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-pyrimidinamine
2,3-Dihydroindol-1-yl-(6-fluoro-2-methyl-4-quinolinyl)methanone
2-(2-furanyl)-5-methyl-6-(phenylmethyl)-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
3-(4-Fluorophenyl)-5-(2-furanyl)-2-phenyl-3,4-dihydropyrazole
(3S)-4-oxo-3-phenyl-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester
5-(3-Hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
(2R)-2-[4-(1H-indol-3-yl)butanoylamino]-3-sulfanylpropanoic acid
(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
(2R,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2R,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2S,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3R,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboximidamide
1-naphthyl beta-D-glucoside
A beta-D-glucoside that is beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 1-naphthyl group.
ML353
ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM) with an Ki value of 18.2 nM. ML353 improves the affinity of common allosteric sites, 20-fold higher than the previous mGlu5 SAM tool compound 5mpep. ML353 has potential applications in solving the intrinsic activity of SAM in vivo or as a agent blocker[1]. ML353 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
5-hydroxy-3-[(2s)-2-hydroxypropyl]-6,8-dimethoxy-2-methylnaphthalene-1,4-dione
(3s,12s,13s)-3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
2-(1,4-dihydroxycyclohexyl)-5-hydroxy-7-methoxychromen-4-one
(1s,2s,4s,5s,6r,10r)-10-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl benzoate
3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-one
[(5s)-5-[(2r)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
(1s,2s,6r,7s,10s,12r,14s)-10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
(3r,3ar,4r,6s)-3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
(9r,10s)-9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
(3s,5r,9s)-15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
methyl 2-[(4s,6s,9z,10r)-6-methyl-8,12-dioxo-5,11-dioxatricyclo[8.2.1.0⁴,⁶]tridec-1(13)-en-9-ylidene]propanoate
3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
1-naphthol-β-d-glucopyranoside
{"Ingredient_id": "HBIN002826","Ingredient_name": "1-naphthol-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "C1=CC=C2C(=C1)C=CC=C2OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-ongokein-4'-one
{"Ingredient_id": "HBIN006819","Ingredient_name": "(2s)-ongokein-4'-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3(CCC(=O)CC3)O)O","Ingredient_weight": "306.31 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16087","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101763963","DrugBank_id": "NA"}
6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one
{"Ingredient_id": "HBIN012009","Ingredient_name": "6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "CC(=O)OC1=C(C=C2C=CC(=O)OC2=C1)CC(C(C)(C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6025","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin
{"Ingredient_id": "HBIN013567","Ingredient_name": "8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "NA","Ingredient_weight": "306.31","OB_score": "NA","CAS_id": "75239-74-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7412","PubChem_id": "NA","DrugBank_id": "NA"}
